Literature DB >> 10852928

Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes.

H Chen1, M Deere, J T Hecht, J Lawler.   

Abstract

Mutations in residues in the type 3 calcium-binding repeats and COOH-terminal globular region of cartilage oligomeric matrix protein (COMP) lead to two skeletal dysplasias, pseudoachondroplasia and multiple epiphyseal dysplasia. It has been hypothesized that these mutations cause COMP to misfold and to be retained in the endoplasmic reticulum. However, this hypothesis is not supported by previous reports that COMP, when purified in the presence of EDTA, shows no obvious difference in electron microscopic appearance in the presence or absence of calcium ions. Since this discrepancy may be due to the removal of calcium during purification, we have expressed wild-type COMP and the most common mutant form found in pseudoachondroplasia, MUT3, using a mammalian expression system and have purified both proteins in the presence of calcium. Both proteins are expressed as pentamers. Direct calcium binding experiments demonstrate that wild-type COMP, when purified in the presence of calcium, is a calcium-binding protein. Rotary shadowing electron microscopy and limited trypsin digestion at various calcium concentrations show that there are conformational changes associated with calcium binding to COMP. Whereas COMP exists in a more compact conformation in the presence of calcium, it shows a more extended conformation when calcium is removed. MUT3, with a single aspartic acid deletion in the type 3 repeats, binds less calcium and presents an intermediate conformation between the calcium-replete and calcium-depleted forms of COMP. In conclusion, we show that a single mutation in the type 3 repeats of COMP causes the mutant protein to misfold. Our data demonstrate the importance of calcium binding to the structure of COMP and provide a plausible explanation for the observation that mutations in the type 3 repeats and COOH-terminal globular region lead to pseudoachondroplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852928     DOI: 10.1074/jbc.M909780199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2.

Authors:  Tina M Misenheimer; Deane F Mosher
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

2.  Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins.

Authors:  Faye Hui Chen; Ashby O Thomas; Jacqueline T Hecht; Mary B Goldring; Jack Lawler
Journal:  J Biol Chem       Date:  2005-07-28       Impact factor: 5.157

3.  Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.

Authors:  Thomas M Merritt; Roger Bick; Brian J Poindexter; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  Structures of thrombospondins.

Authors:  C B Carlson; J Lawler; D F Mosher
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

Review 5.  Novel therapeutic interventions for pseudoachondroplasia.

Authors:  Karen L Posey; Jacqueline T Hecht
Journal:  Bone       Date:  2017-03-21       Impact factor: 4.398

6.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

7.  Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein.

Authors:  Dominik R Haudenschild; Eunmee Hong; Jasper H N Yik; Brett Chromy; Matthias Mörgelin; Kaylene D Snow; Chitrangada Acharya; Yoshikazu Takada; Paul E Di Cesare
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

8.  Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Mohammad G Hossain; Michael J Gambello; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

9.  An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Authors:  Karen L Posey; Alka C Veerisetty; Pieman Liu; Huiqiu R Wang; Brian J Poindexter; Roger Bick; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

10.  Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein.

Authors:  Yoon Hae Kwak; Jae Young Roh; Ki Seok Lee; Hui Wan Park; Hyun Woo Kim
Journal:  Clin Orthop Surg       Date:  2009-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.